This HTML5 document contains 101 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
yago-reshttp://yago-knowledge.org/resource/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n4https://global.dbpedia.org/id/
yagohttp://dbpedia.org/class/yago/
n8http://dbpedia.org/resource/Sulfadoxine/
schemahttp://schema.org/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
n16http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
freebasehttp://rdf.freebase.com/ns/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://www.theglobalfund.org/en/privatesectorcopayment/
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
dbphttp://dbpedia.org/property/
dbchttp://dbpedia.org/resource/Category:
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
goldhttp://purl.org/linguistics/gold/
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:Affordable_Medicines_Facility-malaria
rdf:type
yago:Abstraction100002137 dbo:Organisation schema:Organization yago:SocialGroup107950920 yago:WikicatMalariaOrganizations wikidata:Q43229 dbo:Agent n16:Agent n16:SocialPerson wikidata:Q24229398 owl:Thing yago:WikicatOrganizationsEstablishedIn2007 yago:YagoLegalActor yago:YagoLegalActorGeo yago:Group100031264 yago:YagoPermanentlyLocatedEntity yago:Organization108008335
rdfs:label
Affordable Medicines Facility-malaria
rdfs:comment
The Affordable Medicines Facility-malaria (AMFm) is a financing mechanism intended to expand access to affordable and effective antimalarial medication (artemisinin-based combination therapies, ACTs). It works primarily through the commercial private sector, in addition to the public and non-governmental organization sectors which are the more traditional routes for development assistance in malaria control. Its goal is to drive down the price of the most effective malaria medicines so that millions of people can afford to buy them. The program has been called "one of the most important recent advances in fighting malaria" and "a triumph of international cooperation." The AMFm is hosted and managed by the Global Fund to Fight AIDS, Tuberculosis and Malaria in Geneva, Switzerland.
foaf:name
The Affordable Medicines Facility-malaria (AMFm)
foaf:homepage
n10:
dbp:name
The Affordable Medicines Facility-malaria
dbo:location
dbr:Geneva dbr:Switzerland
dcterms:subject
dbc:Organizations_established_in_2007 dbc:International_organisations_based_in_Switzerland dbc:Malaria_organizations
dbo:wikiPageID
35696179
dbo:wikiPageRevisionID
1059873223
dbo:wikiPageWikiLink
dbr:Development_aid dbr:Zanzibar dbr:Geneva dbr:Roll_Back_Malaria_(RBM)_Partnership dbr:Subsidy dbr:Public_sector dbr:List_of_Nobel_Laureates n8:pyrimethamine dbr:Malaria_vaccines dbr:Artemisinin-based_combination_therapies dbr:Kenya dbr:Artemisinin dbr:Non-governmental_organization dbr:Mosquitoes dbr:World_Health_Organization_(WHO) dbr:Buyers dbr:Cambodia dbr:Madagascar dbr:Co-payment dbr:Global_Fund_to_Fight_AIDS,_Tuberculosis_and_Malaria dbr:Institute_of_Medicine dbr:Indoor_residual_spraying dbr:Niger dbr:The_Global_Fund_to_Fight_AIDS,_Tuberculosis_and_Malaria dbr:Plasmodium_falciparum dbr:Tanzania dbr:Nonprofit_organization dbr:Parasites dbr:Pharmaceutical_industry dbr:Endemic dbc:Organizations_established_in_2007 dbr:Malaria dbr:Drug_resistance dbc:International_organisations_based_in_Switzerland dbr:Ghana dbr:World_Bank dbr:Kenneth_Arrow dbr:Chloroquine dbr:Nobel_Prize dbr:Switzerland dbr:Copenhagen_Consensus dbr:Uganda dbr:Mosquito_net dbr:Combination_therapy dbr:Peer-reviewed_journals dbr:Private_sector dbc:Malaria_organizations dbr:Nigeria dbr:Amodiaquine dbr:Antimalarial_medication dbr:Vector_control dbr:Bill_&_Melinda_Gates_Foundation
dbo:wikiPageExternalLink
n10:
owl:sameAs
n4:4LqMM wikidata:Q4689031 freebase:m.0jt7ylx yago-res:Affordable_Medicines_Facility-malaria
dbp:wikiPageUsesTemplate
dbt:Infobox_non-profit dbt:Reflist dbt:Use_dmy_dates dbt:Notability dbt:Start_date
dbp:areaServed
Phase 1: Cambodia, Ghana, Kenya, Madagascar, Niger, Nigeria, Tanzania , Uganda
dbp:focus
Innovative financing mechanism to expand access to the most effective treatment for malaria, artemisinin-based combination therapies
dbp:foundedDate
and
dbp:homepage
n10:
dbp:location
Geneva, Switzerland
dbo:abstract
The Affordable Medicines Facility-malaria (AMFm) is a financing mechanism intended to expand access to affordable and effective antimalarial medication (artemisinin-based combination therapies, ACTs). It works primarily through the commercial private sector, in addition to the public and non-governmental organization sectors which are the more traditional routes for development assistance in malaria control. Its goal is to drive down the price of the most effective malaria medicines so that millions of people can afford to buy them. The program has been called "one of the most important recent advances in fighting malaria" and "a triumph of international cooperation." The AMFm is hosted and managed by the Global Fund to Fight AIDS, Tuberculosis and Malaria in Geneva, Switzerland. The premise of the AMFm is that a factory-gate global subsidy, with measures to support its implementation, will save lives and reduce malaria-related mortality by increasing access to ACTs, and delay the onset of widespread resistance to the artemisinin in ACTs. It includes three elements: (i) price reductions through negotiations with ACT manufacturers, (ii) a buyer subsidy through a 'co-payment' at the top of the global supply chain and (iii) supporting interventions at the country level to promote the appropriate use of ACTs. AMFm Phase 1 was formally launched in April 2009 and began operations in July 2010. AMFm Phase 1 is being implemented through nine pilot programs in eight countries: Cambodia, Ghana, Kenya, Madagascar, Niger, Nigeria, Tanzania (mainland and Zanzibar) and Uganda. There are early signs AMFm Phase 1 is effectively increasing availability and decreasing prices of ACTs; however the Global Fund Board will only take a decision on the future of AMFm at the end of 2012 on the basis of an independent evaluation. As part of the Copenhagen Consensus 2012, a panel of leading economists concluded that the AMFm was "one of the best returns on health that could be made globally" and ranked it two of 16 priority solutions to advance global welfare. In November 2012 the Global Fund Board decided to modify the existing AMFm business line by integrating lessons learned from Phase 1 into Global Fund core grant management and financial processes. The AMFm was subsequently renamed the Private Sector Co-payment Mechanism.
gold:hypernym
dbr:Mechanism
prov:wasDerivedFrom
wikipedia-en:Affordable_Medicines_Facility-malaria?oldid=1059873223&ns=0
dbo:wikiPageLength
18553
foaf:isPrimaryTopicOf
wikipedia-en:Affordable_Medicines_Facility-malaria